Society Logo
ME/CFS Australia Ltd
Please Click Here To Donate ME/CFS Australia (SA) Inc
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 698

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm
Closed over Christmas
(reopened 1 February 2017)

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 277KB)
Why become a member?

Fibromyalgia Aggravates Pain And Cognitive Capabilities Of Chronic Fatigue Syndrome Patients

Friday 9 October 2015

 

From Fibromyalgia News Today:

 

Knee
 

Fibromyalgia Aggravates Pain and Cognitive Capabilities of Chronic Fatigue Syndrome Patients

Bruno Castro, PhD
October 7th, 2015

A team of researchers from Vrije Universiteit Brussel and the University of Antwerp, in Belgium, found that fibromyalgia increases the disability of Chronic Fatigue Syndrome patients. The study entitled “Associations Between Cognitive Performance and Pain in Chronic Fatigue Syndrome: Comorbidity with Fibromyalgia Does Matter” was recently published in the Pain Physician journal.

Chronic Fatigue Syndrome (CFS) is a debilitating and complex disorder characterized by continuous extreme fatigue that is not alleviated by bed rest, interfering with a person’s well-being. The majority of CFS patients also present widespread and persistent musculoskeletal pain. These symptoms are also the hallmark of fibromyalgia, a chronic disorder of unknown etiology. Fatigue, sleep disturbances, mood disturbances and cognitive dysfunctions are other symptoms shared by CFS and fibromyalgia. Indeed, researchers have shown that CFS patients with and without fibromyalgia have worse cognitive capabilities than healthy persons. In this work, authors investigated the relationship between cognitive performance and self-reported and experimental pain measurements in FCS patients with or without fibromyalgia.

The study included a total of 48 subjects divided into 3 groups: CFS only (18 patients), CFS + fibromyalgia (30 patients) and the healthy control group (30 individuals). Participants completed 3 cognitive performance tests to set their attention, cognitive and memory capacities. Seven days later, participants were subjected to different experimental pain measurements and fill out questionnaires to assess self-reported pain, fatigue and depressive symptoms.

Authors found that CFS patients with comorbid fibromyalgia are the most severely affected, having hyperalgesia, enhanced endogenous pain facilitation, and significantly more depressive symptoms compared to the CFS only and control groups. Significant differences between the CFS + fibromyalgia and the CFS only groups were found only in the case of self-reported pain. These findings suggest that a measure of endogenous pain inhibition might be a predictor of cognitive performance in CFS patient with fibromyalgia, while a self-reported pain measurement could be more useful to predict mental health in FCS patients without fibromyalgia. Authors’ data further confirmed the previously reported heterogeneity within CFS patients. As a final comment, authors suggest that future studies should focus in reducing CFS heterogeneity to unravel and understand the underlying mechanisms of CFS patients’ impairments, which would definitely contribute for the development of efficient guided therapies.

Bruno Castro, PhD
Bruno has a PhD in Chemistry from Instituto Superior Técnico, Technical University of Lisbon, Portugal. He did his undergraduate studies in Biochemistry at the Faculty of Sciences of Lisbon University, Portugal. For the past years he was as a Postdoctoral Researcher at ICFO – The Institute of Photonic Sciences, Barcelona, Spain, working in the intersection between biophysical-chemistry, cell biology and immunology.

© BioNews Services 2015.
All rights reserved.

 

The above originally appeared here.

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus

Previous Previous Page